Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
24.8 EUR
5.42 B EUR
155.24 B EUR
231.45 M
About Elevance Health, Inc.
Sector
Industry
CEO
Gail Koziara Boudreaux
Website
Headquarters
Indianapolis
Founded
1944
FIGI
BBG000BHX743
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ELEVANCE HEALTH DL-,01 stocks are traded under the ticker A58.
We've gathered analysts' opinions on ELEVANCE HEALTH DL-,01 future price: according to them, A58 price has a max estimate of 599.55 EUR and a min estimate of 372.20 EUR. Watch A58 chart and read a more detailed ELEVANCE HEALTH DL-,01 stock forecast: see what analysts think of ELEVANCE HEALTH DL-,01 and suggest that you do with its stocks.
Yes, you can track ELEVANCE HEALTH DL-,01 financials in yearly and quarterly reports right on TradingView.
ELEVANCE HEALTH DL-,01 is going to release the next earnings report on Jan 22, 2025. Keep track of upcoming events with our Earnings Calendar.
A58 earnings for the last quarter are 7.52 EUR per share, whereas the estimation was 8.67 EUR resulting in a −13.33% surprise. The estimated earnings for the next quarter are 3.83 EUR per share. See more details about ELEVANCE HEALTH DL-,01 earnings.
ELEVANCE HEALTH DL-,01 revenue for the last quarter amounts to 40.16 B EUR, despite the estimated figure of 39.04 B EUR. In the next quarter, revenue is expected to reach 43.17 B EUR.
A58 net income for the last quarter is 912.51 M EUR, while the quarter before that showed 2.15 B EUR of net income which accounts for −57.50% change. Track more ELEVANCE HEALTH DL-,01 financial stats to get the full picture.
Yes, A58 dividends are paid quarterly. The last dividend per share was 1.54 EUR. As of today, Dividend Yield (TTM)% is 1.71%. Tracking ELEVANCE HEALTH DL-,01 dividends might help you take more informed decisions.
ELEVANCE HEALTH DL-,01 dividend yield was 1.26% in 2023, and payout ratio reached 23.47%. The year before the numbers were 1.00% and 21.09% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 104.90 K employees. See our rating of the largest employees — is ELEVANCE HEALTH DL-,01 on this list?
Like other stocks, A58 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELEVANCE HEALTH DL-,01 stock right from TradingView charts — choose your broker and connect to your account.